MEDICAL MARIJUANA, INC.

Inactive Instrument

Other languages Medical Marijuana, Inc. Other OTC

Equities

MJNA

US58463A1051

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	23-07-31
Medical Marijuana, Inc. Announces Executive Changes	23-03-14
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer	23-03-14
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies	22-05-26
Medical Marijuana, Inc. Promotes Todd Morrow to President	22-02-10
Kannaway(R), eine Tochtergesellschaft von Medical Marijuana, Inc., gewinnt Verfahren am obersten Verwaltungsgericht zum legalen Import von CBD-Öl nach Finnland	21-10-26
Jushi : Q2 Net Income Rises Year Over Year as Revenues Improve; Set to Open 21st Retail Location Nationwide	21-08-25
Sector Update: Health Care Stocks Back on Positive Ground This Afternoon	21-07-27
Khiron Life Sciences : Up 8.8% as Colombia Expands Medical Marijuana Program and Relaxes Export Rules	21-07-26
Kanabo : UK's Kanabo to buy Canadian cannabis producer Materia	21-07-26
Update: Curaleaf Loses 2% as Opens New Store in Wells, Maine	21-07-23
Jushi : Says Franklin Bioscience OH Begins Operations at Ohio Processing Facility	21-07-07
Agrify : Secures $12 Million Contract From Nevada Medical Marijuana Dispensary	21-06-24
Khiron Life Sciences : First Quarter Loss Narrows on Higher Medical Sales in Colombia	21-05-27
Sector Update: Health Care Stocks Surge Despite Monday Weakness Among Biotech Shares	21-05-03
Medical Marijuana, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-09-05
Medical Marijuana, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-07-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer